| Pathogenesis of systemic lupus erythematosus CC Mok, CS Lau Journal of clinical pathology 56 (7), 481-490, 2003 | 1267 | 2003 |
| Two-year, randomized, controlled trial of belimumab in lupus nephritis R Furie, BH Rovin, F Houssiau, A Malvar, YKO Teng, G Contreras, ... New England Journal of Medicine 383 (12), 1117-1128, 2020 | 716 | 2020 |
| Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus W Yang, N Shen, DQ Ye, Q Liu, Y Zhang, XX Qian, N Hirankarn, D Ying, ... PLoS genetics 6 (2), e1000841, 2010 | 458 | 2010 |
| Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: prevalence, incidence, clinical features, and mortality RW Jakes, SC Bae, W Louthrenoo, CC Mok, SV Navarra, N Kwon Arthritis care & research 64 (2), 159-168, 2012 | 402 | 2012 |
| Interleukin‐10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus CC Mok, JS Lanchbury, D Wai Chan, CS Lau Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 316 | 1998 |
| Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus CC Mok, RCL Kwok, PSF Yip Arthritis & rheumatism 65 (8), 2154-2160, 2013 | 313 | 2013 |
| Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China CC Mok, CL Kwok, LY Ho, PT Chan, SF Yip Arthritis & Rheumatism 63 (5), 1182-1189, 2011 | 285 | 2011 |
| Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups CC Mok, SSK Tang, CH To, M Petri Arthritis & Rheumatism 52 (9), 2774-2782, 2005 | 280 | 2005 |
| A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population CC Mok, KW Lee, CTK Ho, CS Lau, RWS Wong Rheumatology 39 (4), 399-406, 2000 | 278 | 2000 |
| Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference J Floege, SJ Barbour, DC Cattran, JJ Hogan, PH Nachman, SCW Tang, ... Kidney international 95 (2), 268-280, 2019 | 276 | 2019 |
| Biomarkers for lupus nephritis: a critical appraisal CC Mok BioMed Research International 2010 (1), 638413, 2010 | 265 | 2010 |
| Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta‐analysis FB Karassa, A Afeltra, A Ambrozic, DM Chang, F De Keyser, A Doria, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 253 | 2006 |
| Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study CC Mok, LY Ho, LS Fong, CH To Annals of the rheumatic diseases 72 (5), 659-664, 2013 | 237 | 2013 |
| Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis CC Mok, KY Ying, S Tang, CY Leung, KW Lee, WL Ng, RWS Wong, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 237 | 2004 |
| Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups CC Mok, A Mak, WP Chu, CH To, SN Wong Medicine 84 (4), 218-224, 2005 | 232 | 2005 |
| Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis CC Mok, GTC Ko, LY Ho, KL Yu, PT Chan, CH To Arthritis care & research 63 (2), 195-202, 2011 | 229 | 2011 |
| Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians W Yang, H Tang, Y Zhang, X Tang, J Zhang, L Sun, J Yang, Y Cui, ... The American Journal of Human Genetics 92 (1), 41-51, 2013 | 228 | 2013 |
| Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up CC Mok, KY Ying, CW Yim, YP Siu, KH Tong, CH To, WL Ng Annals of the rheumatic diseases 75 (1), 30-36, 2016 | 224 | 2016 |
| Rituximab for the treatment of rheumatoid arthritis: an update CC Mok Drug design, development and therapy, 87-100, 2014 | 219 | 2014 |
| Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. CC Mok, CS Lau, EY Chan, RW Wong The Journal of rheumatology 25 (3), 467-473, 1998 | 215 | 1998 |
